Why Fear Fails: Limitations of Alarmist Tactics and Humanized Approaches in the Prevention and Treatment of Anabolic-Androgenic Steroid Abuse
DOI:
https://doi.org/10.69849/hjdqvj26Keywords:
Anabolic agents, health education, health behavior, harm reduction, physician– patient relationshipsAbstract
The non-therapeutic use of anabolic-androgenic steroids (AAS) has increased across various population groups, particularly among young men and gym attendees, constituting a growing public health challenge. Despite the widespread adoption of fear-based and punitive campaigns, evidence demonstrates that such strategies are ineffective in reducing use and may produce adverse effects. Alarmist messages frequently increase stigma, reinforce user isolation, and reduce the likelihood of seeking medical follow-up. This article critically analyzes the limitations of fear-based tactics by reviewing experimental studies, qualitative research, and systematic reviews on the topic. The findings indicate that fear, by failing to strengthen perceived self-efficacy or promote a sense of personal control, does not effectively modify beliefs or behaviors. In contrast, balanced educational interventions that integrate information about risks and benefits, decision-making skills, and harm reduction strategies show better outcomes in prevention and therapeutic engagement. Programs such as ATLAS and ATHENA have demonstrated sustained effectiveness by promoting critical thinking and individual responsibility. Medical training represents another fundamental element: the lack of specific education in pharmacology and human behavior, combined with institutional censorship, hinders empathetic and evidence-based approaches. It is concluded that addressing AAS use requires abandoning the moralizing paradigm and adopting policies grounded in science, education, empathy, and continuous care.
References
1. Bonnecaze AK, O'Connor T, Burns CA. Harm reduction in male patients actively using anabolic androgenic steroids (AAS) and performance-enhancing drugs (PEDs): a review. J Gen Intern Med. 2021;36(7):2055-2064. doi:10.1007/s11606-021-06751-3
2. Kimergård A, McVeigh J. Environments, risk and health harms: a qualitative investigation into the illicit use of anabolic steroids among people using harm reduction services in the UK. BMJ Open. 2014;4(6):e005275. doi:10.1136/bmjopen-2014-005275
3. Harvey O, Keen S, Parrish M, van Teijlingen E. Support for people who use anabolic androgenic steroids: a systematic scoping review into what they want and what they access. BMC Public Health. 2019;19(1):1024. doi:10.1186/s12889-019-7288-x
4. Rogol AD, Yesalis CE 3rd. Anabolic-androgenic steroids and the adolescent. Pediatr Ann. 1992;21(3):175-188. doi:10.3928/0090-4481-19920301-09
5. Petróczi A, Dodge T, Backhouse S, Adesanwo C. Review of the literature on negative health risk-based interventions to guide anabolic steroid misuse prevention. Perform Enhanc Health. 2014;3(4):100-114. doi:10.1016/j.peh.2014.08.001
6. Goldberg L, Bents R, Bosworth E, Trevisan L, Elliot DL. Anabolic steroid education and adolescents: do scare tactics work? Pediatrics. 1991;87(3):283-286
7. Goldberg L, Elliot D, Clarke GN, et al. Effects of a multidimensional anabolic steroid prevention intervention. The Adolescents Training and Learning to Avoid Steroids (ATLAS) Program. JAMA. 1996;276(19):1555-1562. doi:10.1001/jama.1996.03540190027025
8. Ranby KW, Aiken LS, Mackinnon DP, et al. A mediation analysis of the ATHENA intervention for female athletes: prevention of athletic-enhancing substance use and unhealthy weight loss behaviors. J Pediatr Psychol. 2009;34(10):1069-1083. doi:10.1093/jpepsy/jsp025
9. Halliburton AE, Fritz MS. Health beliefs as a key determinant of intent to use anabolic androgenic steroids (AAS) among high-school football players: implications for prevention. Int J Adolesc Youth. 2018;23(3):269-280. doi:10.1080/02673843.2017.1344928
10. Piatkowski T, Gibbs N, Dunn M. Beyond the law: exploring the impact of criminalising anabolic–androgenic steroid use on help-seeking and health outcomes in Australia. J Criminol. 2024;57(1):62-82. doi:10.1177/26338076231209044
11. Vinther AS. “The challenge is that steroids are so effective”: a qualitative study of experts’ views on strategies to prevent men’s use of anabolic steroids. Contemp Drug Probl. 2023;50(1):85-104. doi:10.1177/00914509221129300
12. Izzat N, Abu-Farha R, Harahsheh MM, Thiab S. A qualitative assessment of anabolic androgenic steroid use among gym users in Jordan: motives, perception, and safety. Int J Legal Med. 2023;137(5):1421-1430. doi:10.1007/s00414-023-03046-6
13. Khalili S, Khoshravesh S, Barati M, Mahjoub H, Faradmal J. Androgenic-anabolic steroids use among bodybuilders in western Iran: application of ridge logistic regression model. BMC Sports Sci Med Rehabil. 2023;15(1):7. doi:10.1186/s13102-023-00616-4
14. Anawalt BD. Diagnosis and management of anabolic androgenic steroid use. J Clin Endocrinol Metab. 2019;104(7):2490-2500. doi:10.1210/jc.2018-01882
15. Jalilian F, Allahverdipour H, Moeini B, Moghimbeigi A. Effectiveness of anabolic steroid preventative intervention among gym users: applying theory of planned behavior. Health Promot Perspect. 2011;1(1):32-40. doi:10.5681/hpp.2011.002
16. Kutscher E, Arshed A, Greene RE, Kladney M. Exploring anabolic androgenic steroid use among cisgender gay, bisexual, and queer men. JAMA Netw Open. 2024;7(5):e2411088. doi:10.1001/jamanetworkopen.2024.11088
17. McVeigh J, Hearne E, Boardley I, et al. Generating evidence on the use of image and performance enhancing drugs in the UK: results from a scoping review and expert consultation by the Anabolic Steroid UK network. Harm Reduct J. 2021;18(1):107. doi:10.1186/s12954-021-00550-z
18. Hoffman JR, Ratamess NA. Medical issues associated with anabolic steroid use: are they exaggerated? J Sports Sci Med. 2006;5(2):182-193
19. Kutscher E, Arshed A, Greene RE, Kladney M. Harm reduction techniques among cisgender gay, bisexual, and queer men using anabolic androgenic steroids: a qualitative study. Harm Reduct J. 2024;21(1):196. doi:10.1186/s12954-024-01121-8
20. Vázquez-Mourelle R, Carracedo-Martinez E, Figueiras A. Impact of health authority control measures aimed at reducing the illicit use of anabolic-androgenic steroids. Eur Addict Res. 2018;24(1):28-36. doi:10.1159/000486852
21. Stojko M, Nocoń J, Piłat P, et al. Innovative reports on the effects of anabolic androgenic steroid abuse-how to lose your mind for the love of sport. Medicina (Kaunas). 2023;59(8):1439. doi:10.3390/medicina59081439
22. Piatkowski T, Dunn M. Navigating risks and reducing harm: a gendered analysis of anabolic–androgenic steroid users within the risk environment framework. Contemp Drug Probl. 2024;51(2):111-128. doi:10.1177/00914509241249292
23. Bates G, Van Hout MC, Teck JTW, McVeigh J. Treatments for people who use anabolic androgenic steroids: a scoping review. Harm Reduct J. 2019;16(1):75. doi:10.1186/s12954- 019-0343-1
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Lucas Caseri Câmara, Matheus Hissa Lourenço Ferreira (Autor)

This work is licensed under a Creative Commons Attribution 4.0 International License.
"Os Autores que publicam nesta revista concordam com os seguintes termos:
-
Os Autores mantêm os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a licença Creative Commons Attribution 4.0 International (CC BY 4.0). Esta licença permite que o trabalho seja compartilhado, copiado e adaptado em qualquer suporte ou formato, para qualquer fim, inclusive comercial, desde que seja atribuído o devido crédito de autoria e de publicação inicial nesta revista.
-
Os Autores têm autorização para assumir compromissos contratuais adicionais separadamente, para a distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.
-
A revista permite e incentiva os autores a publicar e distribuir seu trabalho online (ex.: em repositórios institucionais ou na sua página pessoal) após o processo de edição e publicação, pois isso pode gerar alterações produtivas, bem como aumentar o impacto e a citação do trabalho publicado."